Sanofi's determination to find answers for patients motivates them to develop breakthrough medicines and vaccines.
From Sanofi's beginnings as a local French enterprise to a leading global healthcare company, reinvention is in Sanofi's DNA and reflects their quest to make life better for patients, partners and communities.
Sanofi is driven by cutting-edge science and manufacturing, fuelled by data and digital technologies that have the potential to transform medicine, turning the impossible into possible for millions of people around the world.
Finding the best ways to connect with both medical professionals and patients
BFG Healthcare Consulting helped Sanofi, one of the world’s major pharmaceutical companies, with pre-launch feasibility studies examining innovative ways for their new prescription medicine, Multaq, to best reach medical professionals as well as patients.
Multaq is a drug designed to help regulate abnormal heart rhythms in patients with atrial fibrillation (AFib). Development ideas included specialist workshops and conferences alongside radio and TV programme content, as well as a concept to explore public screening for AFib which was developed to trial stage.
Our work also included looking at the feasibility of partnership agreements with manufacturers and pharmacy retailers to help launch the medicine.